GlassScriptPhysician profile
Mohammad M Nasser
NPI 1376835157
$876.51
in general payments reported to CMS, 2019-2025
20 companies · $109 in 2025
The $109 reported for 2025 was more than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $68.71 · 2021: $179 · 2022: $175 · 2023: $178 · 2024: $167 · 2025: $109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $454.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $453.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $160.40 | 2022-2024 | Accolade Sr |
| Abbott Laboratories | $127.81 | 2022-2025 | Octrode, Freestyle Libre 2, Eterna |
| Lucid Diagnostics INC. | $101.87 | 2021 | |
| Medtronic, INC. | $56.68 | 2022-2025 | Intellis Adaptivestim |
| Teva Pharmaceuticals USA, INC. | $43.17 | 2021-2023 | Austedo |
| Novo Nordisk INC | $41.00 | 2022-2023 | Ozempic, Rybelsus |
| Acadia Pharmaceuticals INC | $39.51 | 2021-2022 | |
| Pfizer INC. | $37.49 | 2020-2024 | |
| Sun Pharmaceutical Industries INC. | $27.93 | 2023 | Blu-U, Odomzo |
| Protega Pharmaceutials INC | $27.92 | 2025 | Roxybond |
| Astrazeneca Pharmaceuticals LP | $26.85 | 2021-2022 | |
| Vapotherm INC | $26.26 | 2021 | |
| Ardelyx, INC. | $25.12 | 2024 | Ibsrela |
| Merck Sharp & Dohme LLC | $24.85 | 2020 | |
| Globus Medical, INC. | $23.29 | 2025 | Senza |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $20.68 | 2023 | Mounjaro |
| Abbvie INC. | $18.29 | 2024 | |
| Dexcom, INC. | $17.79 | 2025 | Dexcom G6 Transmitter |
| Merz North America, INC. | $17.04 | 2020 | |
| Optos, INC. | $12.56 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Nasser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.